LVHN Endures Short-Term Losses for Long-
Posted 4 years ago

Brian A. Nester, DO, President and Chief Executive Officer of Lehigh Valley Health Network in Allentown, Pennsylvania

Lehigh Valley Health Network in Allentown, Penn., first considered a value-based healthcare system in…

LVHN Endures Short-Term Losses for Long-Term …
HPN Leads the Nation in Healthcare Innovation and Progress
Posted 5 years ago

In 1979, Richard Merkin, MD, founded the organization that would eventually become Heritage Provider Network.

In its earliest days, HPN lacked the financial and human capital to provide traditional solutions to…

HPN Leads the Nation in Healthcare Innovation…
MLKCH Opens with a Fresh Culture and a Fresh Start
Posted 5 years ago

In 2007, the historic King Drew Medical Center in Los Angeles, Calif., closed, after years of persistent and unresolvable quality and patient safety problems.

King Drew had originally been founded by…

MLKCH Opens with a Fresh Culture and a Fresh …
Ameritas Keeps Pace with Constantly Changing Marketplace
Posted 5 years ago

Hospitals and physicians aren’t the only ones that have spent the past few years adjusting to the Affordable Care Act. Payers have also had to change up their systems and…

Ameritas Keeps Pace with Constantly Changing …
Queens Boulevard Partners with North Shore-LIJ to Improve Care Continuum for Patients
Posted 5 years ago

Dr. Jonathan Mawere has been with Queens Boulevard Extended Care Facility (QBECF) in Woodside, N.Y., in various capacities since 1999.

Founded in 1995, QBECF is a 280-bed, state-of-the-art nursing facility that…

Queens Boulevard Partners with North Shore-LI…
PreviousNext

J&J vaccine pause a minor blip, but efforts must press on, experts say

New York officials and local experts played up the importance of moving forward with the other two vaccines available, from Pfizer and Moderna, so that the state does not lose its momentum. New York officials and local experts played up the importance of moving forward with the other two vaccines available, from Pfizer and Moderna, […]

VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)
0 comments Read the full article →

Record venture-capital investment brings rise of New York mega startups

New York City startups raised $10.2 billion in venture-capital investment during the first three months of the year, the largest total for any single quarter on record. The top deals focused on the healthcare industry and e-commerce—unsurprising during a pandemic. New York City startups raised $10.2 billion in venture-capital investment during the first three months […]

VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)
0 comments Read the full article →

Anthem, Blackstone launch new joint venture

Anthem has partnered with a major private equity group to scale an AI-powered app that offers an alternative to WebMD. Anthem has partnered with a major private equity group to scale an AI-powered app that offers an alternative to WebMD.

VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)
0 comments Read the full article →

Effort to keep Arkansas Medicaid plan falls short in state Legislature

Arkansas’ Medicaid expansion has sharply divided Republicans, who control a majority of the Legislature, since it was first approved in 2013. Past efforts to reauthorize the program have faced repeated votes before winning narrow approval. Arkansas’ Medicaid expansion has sharply divided Republicans, who control a majority of the Legislature, since it was first approved in […]

VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)
0 comments Read the full article →

Biden begins to undo Trump’s ‘gag rule’ on abortion referrals

The Biden administration began to undo a Trump-era ban on clinics referring women for abortions, a policy directive that drove Planned Parenthood from the federal family planning program and created new complications for women trying to get birth control. The Biden administration began to undo a Trump-era ban on clinics referring women for abortions, a […]

VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)
0 comments Read the full article →

Mayo Clinic launches two tech companies

One of the companies, Anumana, is seeking clearance from the Food and Drug Administration to market an artificial-intelligence tool to detect heart conditions. One of the companies, Anumana, is seeking clearance from the Food and Drug Administration to market an artificial-intelligence tool to detect heart conditions.

VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)
0 comments Read the full article →

A year into pandemic, federal officials design new mask guidelines to better protect more workers

Federal officials announced new measures to help get fresh, new N95 masks to healthcare workers and expand their use in other industries after scientists argued that the highly protective masks are essential to keep workers safe from COVID-19. Federal officials announced new measures to help get fresh, new N95 masks to healthcare workers and expand […]

VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)
0 comments Read the full article →

Bill delaying Medicare cuts heads to Biden’s desk after House passage

The bill, which passed the House Tuesday, will delay the 2% Medicare cuts for the rest of 2021, a win for hospitals and providers. The bill, which passed the House Tuesday, will delay the 2% Medicare cuts for the rest of 2021, a win for hospitals and providers.

VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)
0 comments Read the full article →

FDA, CDC recommend pause of Johnson & Johnson COVID-19 vaccine’s use

FDA, CDC recommend pause of Johnson & Johnson COVID-19 vaccine’s use tjordan_drupal Apr 13, 2021 The Food and Drug Administration and Centers for Disease Control and Prevention today jointly recommended a pause in the use of Johnson & Johnson’s COVID-19 vaccine, following six reported cases of rare but severe types of blood clots following the vaccine’s […]

VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)
0 comments Read the full article →

Regeneron: Antibody cocktail helps prevent symptomatic COVID-19

Regeneron: Antibody cocktail helps prevent symptomatic COVID-19 tjordan_drupal Apr 13, 2021 The monoclonal antibody therapy REGEN-COV (casirivimab with imdevimab) reduced the risk of symptomatic COVID-19 in household contacts of people with SARS-CoV-2 by 81% in a phase 3 clinical trial conducted with the National Institute of Allergy and Infectious Diseases, Regeneron Pharmaceuticals announced yesterday. The Food […]

VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)
0 comments Read the full article →